FoundationOne CDx | Foundation Medicine
FoundationOne®CDx is the first FDA-approved tissue-based broad companion diagnostic (CDx) that is clinically and analytically validated for all solid tumors.
FoundationOne Liquid CDx - Foundation Medicine
What is FoundationOne®Liquid CDx? FoundationOne®Liquid CDx is an FDA-approved companion diagnostic that analyzes guideline-recommended genes from a simple blood draw. …
FoundationOne CDx – P170019/S014 | FDA
2022年6月24日 · FoundationOne CDx is a laboratory test designed to find genetic variations in 324 genes, as well as some specific gene rearrangements and other biomarkers, including …
FoundationOne-CDx™ 技术文档 - 简书
2017年11月30日 · F1CDx 是基于NGS的体外诊断试剂， 用于检测324个基因的SNV/INDEL,CNAs，部分基因的重排，MSI 和 TMB。 它作为一种伴随诊断产品可以检测表1 …
FDA批准F1CDx作为K药在MSI-H泛实体瘤中的伴随诊断 - 健康界
2022年2月26日 · F1CDx是DNA-based NGS的组织体外诊断产品，可检测324个基因的 SNVs，Indels，CNVs和 Rearrangements 四种变异类型及TMB（肿瘤突变负荷）、MSI（微 …
CDx (F1CDx) is a qualitative ne xt-generation sequencing based . in vitro. diagnostic test that uses targeted high throughput hybridization-based capture technology for detection of...
不服不行！全球肿瘤基因检测行业标杆-Foundation Medicine - 知乎
2018年， FDA 批准了首个针对泛肿瘤的全面的伴随诊断检测FoundationOne CDx ，这个产品覆盖324个基因、两个可以预测免疫检查点抑制剂疗效的分子标记（MSI/TMB）、覆盖全部实体瘤 …
FoundationOne®CDx (F1CDx) is a next generation sequencing based in vitro diagnostic device for detection of substitutions, insertion and deletion alterations (indels), and copy number...
FoundationOne®CDx (F1CDx) is a qualitative next-generation sequencing based in vitro diagnostic test that uses targeted high throughput hybridization-based capture technology for …
FoundationOne® CDx (F1CDx) is a next generation sequencing based in vitro diagnostic device for detection of substitutions, insertion and deletion alterations (indels), and copy number …
- 某些结果已被删除